Prevalence and Variation of CHIP in Patients with Aggressive Lymphomas Undergoing CD19-Directed CAR-T Cell Treatment

The authors defined the prevalence and variation of clonal hematopoiesis of indetermined potential (CHIP) over time and assessed the influence on clinical inflammation syndromes, cytopenia and outcome.